Cyclopentyl-[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-8,9,10,11-tetrahydropyrazolo[4,5-a]phenanthridin-3-yl]methanol
C24H24F3N5O — CID 166867789
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cyclopentyl-[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-8,9,10,11-tetrahydropyrazolo[4,5-a]phenanthridin-3-yl]methanol
Cyclopentyl-[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-8,9,10,11-tetrahydropyrazolo[4,5-a]phenanthridin-3-yl]methanol (PubChem CID 166867789) has the molecular formula C24H24F3N5O and a molecular weight of 455.48 g/mol. Its IUPAC name is cyclopentyl-[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-8,9,10,11-tetrahydropyrazolo[4,5-a]phenanthridin-3-yl]methanol.
Molecular Properties
| Compound Name | Cyclopentyl-[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-8,9,10,11-tetrahydropyrazolo[4,5-a]phenanthridin-3-yl]methanol |
|---|---|
| PubChem CID | 166867789 |
| Molecular Formula | C24H24F3N5O |
| Molecular Weight | 455.48 g/mol |
| Exact Mass | 455.19 |
| IUPAC Name | cyclopentyl-[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-8,9,10,11-tetrahydropyrazolo[4,5-a]phenanthridin-3-yl]methanol |
| SMILES | OC(C1CCCC1)n1ncc2c3c4c(c(-c5cn[nH]c5C(F)(F)F)nc3ccc21)CCCC4 |
| InChI | InChI=1S/C24H24F3N5O/c25-24(26,27)22-17(11-28-31-22)21-15-8-4-3-7-14(15)20-16-12-29-32(19(16)10-9-18(20)30-21)23(33)13-5-1-2-6-13/h9-13,23,33H,1-8H2,(H,28,31) |
| InChIKey | QAWMXGDYTJVXMK-UHFFFAOYSA-N |
| XLogP | 5.55 |
| TPSA | 79.62 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.48 |
| LogP ≤ 5 | 5.55 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166867789 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.